Loading
TP
Tetraphase Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by LA JOLLA PHARMACEUTICAL CO, was filed 29 Jul 2020.
Tetraphase Pharmaceuticals Inc: what insiders have been doing
This page follows insider dealings at Tetraphase Pharmaceuticals Inc as filed with SEC (Form 4). No insider at Tetraphase Pharmaceuticals Inc has published a filing in the past twelve months. The most recent one dates from 30 July 2020.
Over the whole record (from 2013), the tally stands at 20 purchases and 80 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
238
Thresholds
n/a
Buy Volume
€25M
20 ops. · all time
Sell Volume
€30M
80 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
RevenueUS$6.6M
Net income-US$62.5M-950.2% margin
Last declaration on 30 July 2020
Declarations238 total
1,419,507 sharesCommon StockSEC:0000919574-20-004739:0
00Common StockSEC:0000919574-20-004739:1
3,737,360 shares@ US$2.0092.1% of flowCommon Stock, par value $0.001 per shareSEC:0000920465-20-000123:0
Canonical exit: 26 Oct 2020 (T+90)
768.65 sharesCommon StockSEC:0000899243-20-020626:0
15,703.4 sharesCommon StockSEC:0000899243-20-020624:0
1,944 sharesCommon StockSEC:0000899243-20-020623:0
191 sharesCommon StockSEC:0000899243-20-020623:1
250 sharesCommon StockSEC:0000899243-20-020621:0
1,345.5 sharesCommon StockSEC:0000899243-20-020625:0
234,698 shares@ US$2.627.9% of flowCommon StockSEC:0000920465-20-000103:0
Canonical exit: 17 Sept 2020 (T+90)
14,507 shares@ US$2.1996.5% of flowCommon StockSEC:0001209191-19-060298:0
524 shares@ US$2.193.5% of flowCommon StockSEC:0001209191-19-060298:1
1,870.35 shares@ US$2.3425.4% of flowCommon StockSEC:0001209191-19-059734:0
5,734.65 shares@ US$2.2574.6% of flowCommon StockSEC:0001209191-19-059734:1
13,913 sharesCommon StockSEC:0001209191-19-044241:0
13,913 sharesCommon StockSEC:0001209191-19-044237:0
4,148 sharesCommon StockSEC:0001209191-19-044237:1
3,337 sharesCommon StockSEC:0001209191-19-004609:0
2,058 sharesCommon StockSEC:0001209191-19-004609:1
18,698 sharesCommon StockSEC:0001209191-19-004607:0
2,058 sharesCommon StockSEC:0001209191-19-004605:0
3,332 sharesCommon StockSEC:0001209191-19-004605:1
4,277 sharesCommon StockSEC:0001209191-19-004602:0
2,058 sharesCommon StockSEC:0001209191-19-004602:1
2,509 sharesCommon StockSEC:0001209191-19-004602:2
25 of 238 declarations
About Tetraphase Pharmaceuticals Inc
Tetraphase Pharmaceuticals Inc is a pharmaceutical company focused on developing new antibiotics. It is listed on the NASDAQ under the ticker TTPH.
